セレコックス錠１００ｍｇ
基本情報
| 項目 | 値 |
|---|---|
| DrugBank ID | DB00482 |
| エビデンスレベル | L5（計算予測のみ） |
| 予測適応症数 | 59 |
| 日本商品名（例） | セレコキシブ錠１００ｍｇ「アメル」, セレコキシブ錠１００ｍｇ「オーハラ」, セレコキシブ錠１００ｍｇ「ケミファ」 |
承認適応症（KEGG）
関節リウマチ
予測適応症（TxGNN）
以下は TxGNN モデルにより予測された潜在的新適応症です。スコアが高いほど関連性が高いと予測されています。
| # | 適応症 | スコア | ソース |
|---|---|---|---|
| 1 | spondyloarthropathy | 99% | DL |
| 2 | juvenile idiopathic arthritis | 99% | DL |
| 3 | spondyloarthropathy, susceptibility to | 99% | DL |
| 4 | osteoarthritis susceptibility | 99% | DL |
| 5 | osteoarthritis | 99% | DL |
| 6 | juvenile arthritis due to defect in LACC1 | 99% | DL |
| 7 | ankylosing spondylitis | 99% | DL |
| 8 | arthropathy | 99% | DL |
| 9 | acromesomelic dysplasia, Hunter-Thompson type | 99% | DL |
| 10 | brachyolmia-amelogenesis imperfecta syndrome | 99% | DL |
| 11 | rheumatoid vasculitis | 99% | DL |
| 12 | myosclerosis | 99% | DL |
| 13 | hypermobility of coccyx | 99% | DL |
| 14 | brachyolmia | 99% | DL |
| 15 | rheumatoid nodulosis | 99% | DL |
| 16 | rheumatoid factor-positive polyarticular juvenile idiopathic arthritis | 99% | DL |
| 17 | inflammatory spondylopathy | 99% | DL |
| 18 | WHIM syndrome | 99% | DL |
| 19 | Kummell disease | 99% | DL |
| 20 | juvenile chronic polyarthritis | 99% | DL |
| 21 | polyarticular juvenile rheumatoid arthritis | 99% | DL |
| 22 | rheumatoid arthritis | 99% | DL |
| 23 | vertebral disease | 99% | DL |
| 24 | pseudoachondroplasia | 99% | DL |
| 25 | brachydactyly-syndactyly syndrome | 99% | DL |
| 26 | colobomatous microphthalmia-rhizomelic dysplasia syndrome | 99% | DL |
| 27 | leukoplakia | 98% | DL |
| 28 | mendelian susceptibility to mycobacterial diseases due to complete IL12B deficiency | 98% | DL |
| 29 | combined immunodeficiency due to moesin deficiency | 98% | DL |
| 30 | psoriasis-related juvenile idiopathic arthritis | 97% | DL |
| 31 | hypotrichosis simplex of the scalp | 97% | DL |
| 32 | diffuse alopecia areata | 97% | DL |
| 33 | gout | 97% | DL |
| 34 | congenital hypotrichosis milia | 97% | DL |
| 35 | vertebral joint disease | 96% | DL |
| 36 | ankylosis (disease) | 96% | DL |
| 37 | avascular necrosis of femoral head, primary | 96% | DL |
| 38 | transient arthropathy | 96% | DL |
| 39 | ganglion or cyst of synovium/tendon/bursa | 95% | DL |
| 40 | Behcet syndrome arthropathy | 95% | DL |
| 41 | shoulder impingement syndrome | 95% | DL |
| 42 | de Quervain disease | 95% | DL |
| 43 | articular cartilage disease | 95% | DL |
| 44 | tenosynovitis | 94% | DL |
| 45 | qualitative platelet defect | 94% | DL |
| 46 | fibroma | 94% | DL |
| 47 | bursitis | 94% | DL |
| 48 | Czech dysplasia, metatarsal type | 93% | DL |
| 49 | gingival hypertrophy | 93% | DL |
| 50 | spondyloepimetaphyseal dysplasia, Handigodu type | 93% | DL |
（上位50件を表示。全59件の予測があります）
免責事項
これらの予測は研究目的のみであり、医療アドバイスを構成するものではありません。 臨床応用には必ず適切な検証が必要です。